Protective effects of SGLT2 inhibitor luseogliflozin on pancreatic β‐cells in db/db mice: The earlier and longer, the better

Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-.

Source: Diabetes, Obesity and Metabolism - June 6, 2018 Category: Endocrinology Authors: Tomohiko Kimura , Atsushi Obata , Masashi Shimoda , Seizo Okauchi , Yukiko Kanda ‐Kimura , Yuka Nogami , Saeko Moriuchi , Hidenori Hirukawa , Kenji Kohara , Shuhei Nakanishi , Tomoatsu Mune , Kohei Kaku , Source Type: research